BenjaminIzarMD

Clinical Fellow in Medicine, Massachusetts General Hospital

Overview of Dr. Izar

Dr. Benjamin Izar is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Giessen Faculty of Medicine and has been in practice 7 years. He is one of 117 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 379 doctors at New York-Presbyterian Hospital who specialize in Oncology. He also speaks multiple languages, including German. He has more than 80 publications and over 500 citings.

Office
161 Fort Washington Ave
Fl 9
New York, NY 10032
Book by Phone+1(929) 334-3644

Education & Training

Massachusetts General HospitalInternship, Internal Medicine, 2011 - 2012
University of Giessen Faculty of MedicineClass of 2010

Certifications & Licensure

NY State Medical License 2019 - 2025
MA State Medical License 2014 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

66 citations
Non-cell-autonomous cancer progression from chromosomal instability.
Jun Li, Melissa J Hubisz, Ethan M Earlie, Mercedes A Duran, Christy Hong
Nature. 2023-08-01
2770 citations
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh, Benjamin Izar, Sanjay M. Prakadan, Marc H. Wadsworth, Daniel J. Treacy
Science. 2016-04-08
13 citations
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion.
Giuseppe Leuzzi, Alessandro Vasciaveo, Angelo Taglialatela, Xiao Chen, Tessa M Firestone
Cell. 2024-02-15

Lectures

Single-cell RNA-sequencing and -imaging of melanoma ecosystems reveals sources of resistance to immune checkpoint blockade.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018